ABIVAX Société Anonyme (ABVX)
NASDAQ: ABVX · Real-Time Price · USD
90.20
-1.24 (-1.36%)
At close: Nov 12, 2026, 4:00 PM EST
89.80
-0.40 (-0.44%)
After-hours: Nov 12, 2026, 7:39 PM EST
ABIVAX Société Anonyme Employees
ABIVAX Société Anonyme had 98 employees as of June 30, 2026. The number of employees increased by 29 or 42.03% compared to the same quarter last year.
Employees
98
Change (1Y)
29
Growth (1Y)
42.03%
Revenue / Employee
$54,419
Profits / Employee
-$4,677,323
Market Cap
7.95B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2026 | 98 | 29 | 42.03% | 98 | 0 |
| Mar 31, 2026 | 80 | 11 | 15.94% | 80 | 0 |
| Dec 31, 2025 | 69 | 0 | - | 69 | 0 |
| Sep 30, 2025 | 67 | 5 | 8.06% | 67 | 0 |
| Jun 30, 2025 | 69 | 7 | 11.29% | 69 | 0 |
| Mar 31, 2025 | 69 | 8 | 13.11% | 69 | 0 |
| Dec 31, 2024 | 69 | 8 | 13.11% | 69 | 0 |
| Jun 30, 2024 | 62 | - | - | 62 | 0 |
| Dec 31, 2023 | 61 | 37 | 154.17% | 61 | 0 |
| Dec 31, 2022 | 24 | 0 | - | 24 | 0 |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Axsome Therapeutics | 1,390 |
| Twist Bioscience | 979 |
| Corcept Therapeutics | 730 |
| Arrowhead Pharmaceuticals | 711 |
| ImmunityBio | 691 |
| Cytokinetics | 673 |
| Rhythm Pharmaceuticals | 414 |
ABVX News
- 2 days ago - ABIVAX Société Anonyme Transcript: 3rd Annual Guggenheim Healthcare Innovation Conference - Transcripts
- 10 days ago - Abivax to Participate in Upcoming Fall Investor Conferences - GlobeNewsWire
- 7 weeks ago - Abivax price target lowered to $118 from $140 at Wedbush - TheFly
- 7 weeks ago - Abivax price target lowered to $151 from $155 at Truist - TheFly
- 7 weeks ago - Abivax appoints Chris Rabbat as Chief Medical Officer - TheFly
- 7 weeks ago - Abivax Presents Business Updates and First Half 2026 Financial Results - GlobeNewsWire
- 7 weeks ago - ABIVAX Société Anonyme Earnings release: Q2 2026 - Filings
- 7 weeks ago - ABIVAX Société Anonyme Quarterly report: Q2 2026 - Filings